Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model

References

• Darabi P, Khazali H, Mehrabani Natanzi M. Therapeutic potentials of the natural plant flavonoid apigenin in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant activity. Gynecol Endocrinol. 2019;36(7):582–587.
   PubMed Web of Science ®Google Scholar
• Jafari Khorchani M, Zal F, Neisy A. The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat. Reprod Fertil Dev. 2020;32(3):313–321.
   PubMed Web of Science ®Google Scholar
• Qi B, Shi C, Meng J, et al. Resveratrol alleviates ethanol-induced neuroinflammation in vivo and in vitro: involvement of TLR2-MyD88-NF-κB pathway. Int J Biochem Cell Biol. 2018;103:56–64.
   PubMed Web of Science ®Google Scholar
• Gao Y, Kang L, Li C, et al. Resveratrol ameliorates diabetes-induced cardiac dysfunction through AT1R-ERK/p38 MAPK signaling pathway. Cardiovasc Toxicol. 2016;16(2):130–137.
   PubMed Web of Science ®Google Scholar
• Guo S, Yao Q, Ke Z, et al. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol Cell Endocrinol. 2015;412:85–94.
   PubMed Web of Science ®Google Scholar
• Harati K, Slodnik P, Chromik AM, et al. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res. 2015;35(2):767–774.
   PubMed Web of Science ®Google Scholar
• Wu XP, Xiong M, Xu CS, et al. Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation. Acta Pharmacol Sin. 2015;36(3):353–361.
   PubMed Web of Science ®Google Scholar
• Singh CK, Kumar A, Hitchcock DB, et al. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res. 2011;55(8):1186–1196.
   PubMed Web of Science ®Google Scholar
• MacCarrone M, Lorenzon T, Guerrieri P, et al. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem. 1999;265(1):27–34.
   PubMedGoogle Scholar
• Kong XX, Fu YC, Xu JJ, et al. Resveratrol, an effective regulator of ovarian development and oocyte apoptosis. J Endocrinol Invest. 2011;34(11):e374–e381.
   PubMed Web of Science ®Google Scholar
• Liu Y, He XQ, Huang X, et al. Resveratrol protects mouse oocytes from methylglyoxal-induced oxidative damage. PLoS One. 2013;8(10):e77960.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu X, Zhuang L, et al. Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K/AKT and MAPK pathways. Regul Toxicol Pharmacol. 2020;110:104544.
   PubMed Web of Science ®Google Scholar
• Brenjian S, Moini A, Yamini N, et al. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol. 2020;83(1):e13186.
   PubMed Web of Science ®Google Scholar
• Mostafavi-Pour Z, Khademi F, Zal F, et al. In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: oxidative stress and alpha2 and beta1 integrin subunits expression. Hepat Mon. 2013;13(8):e11447.
   PubMed Web of Science ®Google Scholar
• Ghowsi M, Khazali H, Sisakhtnezhad S. The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: an experimental study. Int J Reprod Biomed. 2018;16(3):149–158.
   PubMed Web of Science ®Google Scholar
• Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3–63.
   PubMed Web of Science ®Google Scholar
• Garruti G, de Palo R, Rotelli MT, et al. Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int. 2014;2014:980429.
   PubMed Web of Science ®Google Scholar
• Patel S. Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: a comprehensive review. J Steroid Biochem Mol Biol. 2017;168:19–25.
   PubMed Web of Science ®Google Scholar
• Morita Y, Wada-Hiraike O, Yano T, et al. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary. Reprod Biol Endocrinol. 2012;10:14.
   PubMed Web of Science ®Google Scholar
• Solak KA, Wijnolts FMJ, Nijmeijer SM, et al. Excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of KGN human granulosa-derived tumor cells. Toxicol Rep. 2014;1:360–372.
   PubMedGoogle Scholar
• Carmina E, Fruzzetti F, Lobo RA. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function. Gynecol Endocrinol. 2018;34(4):301–304.
   PubMed Web of Science ®Google Scholar
• Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005;6(1):13–21.
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–1935.
   PubMed Web of Science ®Google Scholar
• Sepilian V, Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig. 2005;12(2):129–134.
   PubMedGoogle Scholar
• Yildiz Y, Ozaksit G, Serdar Unlu B, et al. Serum adiponectin level and clinical metabolic, and hormonal markers in patients with polycystic ovary syndrome. Int J Fertil Steril. 2014;7(4):331–336.
   PubMedGoogle Scholar
• Comim FV, Hardy K, Franks S. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One. 2013;8(11):e80416.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang H, Li Q, et al. The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat. Gynecol Endocrinol. 2017;33(6):438–441.
   PubMed Web of Science ®Google Scholar
• Caldwell LK, Pierce AL, Riley LG, et al. Plasma nesfatin-1 is not affected by long-term food restriction and does not predict rematuration among iteroparous female rainbow trout (Oncorhynchus mykiss). PLoS One. 2014;9(1):e85700.
   PubMed Web of Science ®Google Scholar
• Deniz R, Gurates B, Aydin S, et al. Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine. 2012;42(3):694–699.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Cheng X, Cui Y, et al. Resveratrol regulates skeletal muscle fibers switching through the AdipoR1-AMPK-PGC-1α pathway. Food Funct. 2019;10(6):3334–3343.
   PubMed Web of Science ®Google Scholar
• Hoseini A, Namazi G, Farrokhian A, et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct. 2019;10(9):6042–6051.
   PubMed Web of Science ®Google Scholar
• Yang C, Deng Q, Xu J, et al. Sinapic acid and resveratrol alleviate oxidative stress with modulation of gut microbiota in high-fat diet-fed rats. Food Res Int. 2019;116:1202–1211.
   PubMed Web of Science ®Google Scholar